SPY300.67-2.30 -0.76%
DIA252.11-2.24 -0.88%
IXIC9,334.57-34.42 -0.37%

Oppenheimer Maintains Outperform on Zimmer Biomet Holdings, Lowers Price Target to $138

Oppenheimer maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and lowers the price target from $141 to $138.

Benzinga · 05/12/2020 12:24

Oppenheimer maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and lowers the price target from $141 to $138.